Björn Högberg

Björn Högberg

Auto-generated profile, based on publicly available information

Björn Högberg

Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2009 in Nature
Verified
Journal Article
Closed access
PDF file
SDShawn Douglas
Shawn Douglas
HDHendrik Dietz
Hendrik Dietz
TLTim Liedl
Tim Liedl
BHBjörn Högberg
Björn Högberg
FGFranziska Graf
Franziska Graf
WSWilliam M. Shih
William M. Shih

22 July 2015 in Nature
Verified
Journal Article
Closed access
EBErik Benson
Erik Benson
AMAbdulmelik Mohammed
Abdulmelik Mohammed
JGJohan Gardell
Johan Gardell
SMSergej Masich
Sergej Masich
ECEugen Czeizler
Eugen Czeizler
BHBjörn Högberg
Björn Högberg

5 September 2012 in ACS Nano
Verified
Journal Article
Open access
YZYong-Xing Zhao
Yong-Xing Zhao
ASAlan Shaw
Alan Shaw
XZXianghui Zeng
Xianghui Zeng
EBErik Benson
Erik Benson
ANAndreas M. Nyström
Andreas M. Nyström
BHBjörn Högberg
Björn Högberg
In the assembly of DNA nanostructures, the specificity of Watson–Crick base pairing is used to control matter at the nanoscale. Using this technology for drug delivery is a promising route toward the magic bullet concept, as it would allow the realization of complex assemblies that co-localize drugs, targeting ligands and other functionalities in one nanostructure. Anthracyclines' mechanism of action in cancer therapy is to intercalate DNA, and since DNA nanotechnology allows for such a high degree of customization, we hypothesized that this would allow us to tune the DNA nanostructures for optimal delivery of the anthracycline doxorubicin (Dox) to human breast cancer cells. We have tested two DNA origami nanostructures on three different breast cancer cell lines (MDA-MB-231, MDA-MB-468, and MCF-7). The different nanostructures were designed to exhibit varying degrees of global twist, leading to different amounts of relaxation in the DNA double-helix structure. By tuning the nanostructure design we are able to (i) tune the encapsulation efficiency and the release rate of the drug and (ii) increase the cytotoxicity and lower the intracellular elimination rate when compared to free Dox. Enhanced apoptosis induced by the delivery system in breast cancer cells was investigated using flow cytometry. The findings indicate that DNA origami nanostructures represent an efficient delivery system for Dox, resulting in high degrees of internalization and increased induction of programmed cell death in breast cancer cells. In addition, by designing the structures to exhibit different degrees of twist, we are able to rationally control and tailor the drug release kinetics.

23 September 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
ISIoanna Smyrlaki
Ioanna Smyrlaki
MEMartin Ekman
Martin Ekman
ALAntonio Lentini
Antonio Lentini
NSNuno André Ramos Rufino de Sousa
Nuno André Ramos Rufino de Sousa
NPNatali Papanicolaou
Natali Papanicolaou
BRBjörn Reinius
Björn Reinius
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is commonly diagnosed by reverse transcription polymerase chain reaction (RT-PCR) to detect viral RNA in patient samples, but RNA extraction constitutes a major bottleneck in current testing. Methodological simplification could increase diagnostic availability and efficiency, benefitting patient care and infection control. Here, we describe methods circumventing RNA extraction in COVID-19 testing by performing RT-PCR directly on heat-inactivated or lysed samples. Our data, including benchmarking using 597 clinical patient samples and a standardised diagnostic system, demonstrate that direct RT-PCR is viable option to extraction-based tests. Using controlled amounts of active SARS-CoV-2, we confirm effectiveness of heat inactivation by plaque assay and evaluate various generic buffers as transport medium for direct RT-PCR. Significant savings in time and cost are achieved through RNA-extraction-free protocols that are directly compatible with established PCR-based testing pipelines. This could aid expansion of COVID-19 testing.

20 June 2010 in Nature Nanotechnology
Verified
Journal Article
Open access
PDF file
TLTim Liedl
Tim Liedl
BHBjörn Högberg
Björn Högberg
JTJessica Tytell
Jessica Tytell
DIDonald E. Ingber
Donald E. Ingber
WSWilliam M. Shih
William M. Shih
Tensegrity, or tensional integrity, is a property of a structure indicating a reliance on a balance between components that are either in pure compression or pure tension for stability1,2. Tensegrity structures exhibit extremely high strength-to-weight ratios and great resilience, and are therefore widely used in engineering, robotics and architecture3,4. Here, we report nanoscale, prestressed, three-dimensional tensegrity structures in which rigid bundles of DNA double helices resist compressive forces exerted by segments of single-stranded DNA that act as tension-bearing cables. Our DNA tensegrity structures can self-assemble against forces up to 14 pN, which is twice the stall force of powerful molecular motors such as kinesin or myosin5,6. The forces generated by this molecular prestressing mechanism can be used to bend the DNA bundles or to actuate the entire structure through enzymatic cleavage at specific sites. In addition to being building blocks for nanostructures, tensile structural elements made of single-stranded DNA could be used to study molecular forces, cellular mechanotransduction and other fundamental biological processes.

6 July 2014 in Nature Methods
Verified
Journal Article
Closed access
ASAlan Shaw
Alan Shaw
VLVanessa Lundin
Vanessa Lundin
EPEkaterina Petrova
Ekaterina Petrova
FFFerenc Fördős
Ferenc Fördős
EBErik Benson
Erik Benson
ATAna I Teixeira
Ana I Teixeira